
AutoGenomics: Pioneering automated, multiplexing molecular diagnostics via microarray platforms.
Founded in 1999, AutoGenomics is dedicated to pioneering automated, multiplexing molecular diagnostics through advanced microarray platforms. The company's core mission is to empower clinical laboratories by providing a fully integrated system for performing a broad range of automated, cost-effective, and user-friendly tests with high accuracy and sensitivity. AutoGenomics focuses on the healthcare and medical diagnostics market, offering products that streamline and enhance the efficiency of diagnostic testing.
Notable figures affiliated with AutoGenomics include its team of scientists and engineers who have driven innovation since its inception. The company has garnered attention from key investors in the biotech and healthcare sectors. AutoGenomics' significant achievements include the development of a comprehensive suite of diagnostic tests that have improved laboratory workflows and patient outcomes. Overall, AutoGenomics has made a substantial impact on the field of molecular diagnostics by enhancing the precision and accessibility of diagnostic testing.

Arrayit
arrayit.com

PathogenDx
pathogendx.com

Myriad Genetics
myriad.com

Exagen
exagen.com

NexGen Arrays

Pacgenomics
pacgenomics.com

ID Genomics
idgenomics.com

LabGenomics Co.

Prompt Diagnostics
prompt-dx.com

Complete Omics
completeomics.com

GeneCapture
genecapture.com

Genalyte
genalyte.com

Lightspeed Genomics

Pointcare Genomics

HTG Molecular Diagnostics
htgmolecular.com
Companies similar to Autogenomics include Arrayit, PathogenDx, Myriad Genetics and Exagen.
Autogenomics was founded in 1999.
Autogenomics' headquarters is located in Vista, CA, US.
Autogenomics' most recent funding round was for $165.6k (USD) in January 2013.
As of Jan 11, 2013, Autogenomics has raised a total of $67.4M (USD).